4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002034668-25-000012
Chief Financial Officer sold 9,200 shares at $18.31 ($168,492)
- Chief Financial Officer acquired 9,200 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hyep Ivan · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,200 | $3.79 | $34,866 | 154,555 | D |
| 2025-12-22 | Sale : show line 2 in the form 10b5-1 | −9,200 | $18.31 | $168,492 | 145,355 | D |
| Open-market sales · 9,200 sh · avg $18.31 · $168,492 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-22 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −9,200 | 88,984 | D |
Loading xslF345X05/wk-form4_1766523739.xml…